Carson Wealth (CWM LLC)’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
Other funds holding AGIO
FCM
AC
LCM
EAM
Carson Wealth (CWM LLC)'s AGIO Position: Q1 2026 in Review
Carson Wealth (CWM LLC) increased its Agios Pharmaceuticals (AGIO) stake by 165% in Q1 2026, buying an estimated $22.6K and bringing the position to 1,281 shares worth $43.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3915.
Carson Wealth (CWM LLC) first reported a position in AGIO in Q1 2019 and has held it in 28 quarters since. The position peaked at $192K in Q3 2025. 233 funds tracked by Wall St. Rank hold AGIO as of Q1 2026.
- Carson Wealth (CWM LLC) held 1,281 shares of Agios Pharmaceuticals worth $43.3K as of Q1 2026.
- Carson Wealth (CWM LLC) bought 797 Agios Pharmaceuticals shares in Q1 2026, an estimated $22.6K.
- Agios Pharmaceuticals made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #3915 holding.
- Carson Wealth (CWM LLC) first reported a position in Agios Pharmaceuticals in Q1 2019 and has held it in 28 quarters since.
- Carson Wealth (CWM LLC)'s Agios Pharmaceuticals position peaked at $192K in Q3 2025.
- 233 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2026.
Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.